Thursday, 02 December 2021

 

 

LATEST NEWS Arvind Kejriwal gives fourth guarantee to Punjabis about education Pargat Singh hands appointment letters to newly recruited Assistant Professors & Librarians for Government Colleges My complexion may be dark but my intentions very clear : Arvind Kejriwal Kriti Sanon joins the cast of 'Shehzada' in Delhi Ekta Kapoor has her plate full with 24 projects lined up for 2022 Ankita Lokhande on connecting with her role in 'Pavitra Rishta 2' Dia Mirza pledges financial aid to frontline forest warriors Pathankot engrossed in Kejriwal's 'Tricolor Yatra' CM Channi's Dream Project, Raja Warring Lays Foundation Stone Of Modern Bus Stand Kharar To Be Built At A Cost Of 6.57 Crores Wont Be A Surprise If Bikram Majithia Follows Sirsa To Join Bjp Soon : Amrinder Singh Raja Warring Jingle Bell-Jingle Bell ‘Shava Ni Girdhari Lal’ Rings the Bell Block Diwas Dr Samoon visits Hajin, Sumbal JKACS organises various activities to commemorate World AIDS Day DG IMPARD chairs online conference regarding Kashmir Aelamia Declaration, 2021 Weekly Block Diwas: Public Grievance redressal camp held at Baggan- Billawar Bulletin on COVID-19 : JK reports 234 new positive cases, 330922 recovered, 1,66,81,244 Covid doses administered so far DC Kupwara inspects 10 MVA RS Hyhama, RS Galizoo Daylong Tosa Maidan festival held at Sitaharan DC Srinagar chairs District Level Armed Forces Committee meet for commemoration of Flag Day Mega Registration camps to be held in Srinagar for enrolment of beneficiaries under PMJAY-SEHAT Div Com visits Mantalai, Sudhmahadev; listens to public grievances, reviews progress on Yoga centre

 

Exposure to harmless coronaviruses boosts SARS-CoV-2 immunity: Study

Delta Plus Covid variant, Delta Covid-19 variant, Coronavirus, Health, Research, Study, Researchers, COVID 19, Novel Coronavirus, Fight Against Corona, Covaxin, Covishield, Oxygen, Oxygen Cylinders, SARS-CoV-2, Sputnik V, Oxygen Plants, Pfizer, Astra Zeneca, Oxygen Concentrator, Remdesivir, Oxygen supply, Liquid Medical Oxygen, Oximeter

Web Admin

Web Admin

5 Dariya News

London , 23 Nov 2021

Previous antibody responses to other, harmless coronaviruses may confer immunity against SARS-CoV-2, the virus that causes Covid-19, according to a new study.The study, published in the journal Nature Communications, showed that people infected with Covid had lower levels of antibodies against coronaviruses that cause common colds compared to uninfected people.In addition, people with high levels of antibodies against harmless coronaviruses were less likely to have been hospitalised after catching Covid.aceOur study shows that a strong antibody response to human coronaviruses increases the level of antibodies against SARS-CoV-2. So someone who has gained immunity to harmless coronaviruses is therefore also better protected against severe SARS-CoV-2 infections," said Alexandra Trkola, head of the Institute of Medical Virology at University of Zurich (UZH).This type of immune response is referred to as cross-reactivity, and it also occurs with T-cell responses, the additional line of the immune system in the defense against infections.In the study, the team used a specially developed assay to analyse antibody levels against four other human coronaviruses in 825 serum samples taken before Covid emerged. They also examined 389 samples from donors infected with Covid. 

Combining these analyses with computer-based models enabled the team to precisely predict how well the antibodies would bind to and neutralise invading viruses.People get fully protected against Covid shortly after they have recovered from an infection or have received an effective vaccination. This is when antibody levels against the virus are still very high. As these levels drop over time, infection is no longer prevented, but the immunological memory quickly reactivates the body's defenses, the production of antibodies as well as the T-cell defense."Of course, immune responses targeting SARS-CoV-2 that are mounted by the memory cells are far more effective than cross-reactive responses. But even though the protection isn't absolute, cross-reactive immune responses shorten the infection and reduce its severity. And this is exactly what is also achieved through vaccination, just much, much more efficiently," Trkola said.It is, however, not yet known whether this cross-reactivity also works in the opposite direction. Whether immunity to Covid -- achieved through vaccination, for example -- also offers protection against other human coronaviruses still needs to be elucidated."If SARS-CoV-2 immunity also offers some degree of protection from infection with other coronaviruses, we would be a significant step closer to achieving comprehensive protection against other coronaviruses, including any new variants," the virologist explains.This idea is also supported by the fact that cross-reactive protection is not only based on antibodies, but very likely also on T cells.

 

Tags: Delta Plus Covid variant , Delta Covid-19 variant , Coronavirus , Health , Research , Study , Researchers , COVID 19 , Novel Coronavirus , Fight Against Corona , Covaxin , Covishield , Oxygen , Oxygen Cylinders , SARS-CoV-2 , Sputnik V , Oxygen Plants , Pfizer , Astra Zeneca , Oxygen Concentrator , Remdesivir , Oxygen supply , Liquid Medical Oxygen , Oximeter

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2021 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD